Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

NCT04352608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

NCT05079217 ·Status: UNKNOWN ·Phase: PHASE4

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

NCT04674189 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018

NCT05228613 ·Status: COMPLETED ·Phase: PHASE1

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097 ·Status: COMPLETED ·Phase: PHASE2

Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection

NCT04690387 ·Status: COMPLETED ·Phase: PHASE1

UNAIR Inactivated COVID-19 Vaccine

NCT05226429 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

NCT04523571 ·Status: COMPLETED ·Phase: PHASE1

Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine

NCT04944381 ·Status: UNKNOWN ·Phase: NA

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above

NCT05198596 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

NCT04649021 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants

NCT04505722 ·Status: COMPLETED ·Phase: PHASE3

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373472 ·Status: COMPLETED ·Phase: PHASE2

Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19

NCT05047718 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of COVID19 Vaccine on the Market

NCT05890521 ·Status: UNKNOWN ·Phase: PHASE4

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

NCT05043311 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

NCT05330871 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults

NCT05011526 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease

NCT05043246 ·Status: UNKNOWN

Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

NCT05855408 ·Status: UNKNOWN ·Phase: PHASE4

Characterization and Durability of COVID-19 Vaccine Induced Immune Responses in Healthcare/Frontline Workers

NCT05049187 ·Status: COMPLETED

A Study of Ad26.COV2.S in Adults (COVID-19)

NCT04509947 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

NCT05004181 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

NCT05067946 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3